Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial
Topic / Pathology
- Parkinson's Disease
Objectives
To have more informations, click on the link below:
https://clinicaltrials.gov/ct2/show/NCT02641054?term=CT-CVXL-0107-01&cond=parkinson&draw=2&rank=1
Sponsor
CleveXel Pharma
Investigator
Pr Jean-Christophe Corvol
Scientific publication(s)
-
Corvol JC et al. Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial
Parkinsonism Relat Disord. 2019 Mar;60:51-56.
Status
Published results
